For example, IL26 is a unique, clinically relevant, inflammatory amplifier that enhances TNBC (triple negative breast cancer) engraftment and dissemination in association with neutrophils, which has the potential as a therapeutic target (26). This evidence concerns the gene IL26 and triple-negative breast carcinoma.